ArticleOncotarget2017

Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.

Paavo O Pietarinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.